APA (7th ed.) Citation

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy, & ProQuest (Firm). (1992). The safety and effectiveness of the abortifacient RU486 in foreign markets: Opportunities and obstacles to U.S. commercialization : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, December 5, 1991. U.S. G.P.O..

Chicago Style (17th ed.) Citation

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy, and ProQuest (Firm). The Safety and Effectiveness of the Abortifacient RU486 in Foreign Markets: Opportunities and Obstacles to U.S. Commercialization : Hearing Before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, First Session, Washington, DC, December 5, 1991. Washington: U.S. G.P.O., 1992.

MLA (9th ed.) Citation

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy, and ProQuest (Firm). The Safety and Effectiveness of the Abortifacient RU486 in Foreign Markets: Opportunities and Obstacles to U.S. Commercialization : Hearing Before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, First Session, Washington, DC, December 5, 1991. U.S. G.P.O., 1992.